¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"dose limiting factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
booster dose
1. Ãß°¡¿ë·® 2. Ãß°¡Á¢Á¾·®
collective effective dose
Áý´ÜÀ¯È¿¼±·®
committed dose equivalent
¿¹Å¹¼±·®ÇØ´ç·®
committed effective dose
¿¹Å¹À¯È¿¼±·®
cumulative dose
1. ´©Àû¿ë·® 2. ´©Àû¼±·®
curative dose
1. Ä¡À¯¿ë·® 2. Ä¡À¯¼±·®
depth dose
½ÉºÎ¼±·®
depth dose curve
½ÉºÎ¼±·®°î¼±
dose
1. ¿ë·®, Åõ¿©·® 2. ¼±·®, Á¶»ç·®
dose distribution
¹æ»ç¼±·®ºÐÆ÷
dose profile
¹æ»ç¼±·®Ãø¸éµµ
dose rate
1. ¼±·®·ü 2. Åõ¿©·®
dose rate effect
¼±·®·üÈ¿°ú
dose rate meter
¼±·®·ü°è, ¼±·®·üÃøÁ¤±â
dose-response curve
¿ë·®¹ÝÀÀ°î¼±
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
coagulation V factor
Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
exclusion of confounding factor
±³¶õº¯¼ö¹èÁ¦
growth factor
¼ºÀåÀÎÀÚ
intrinsic factor
³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acceptable daily dose
ÀÏÀÏÇã¿ë·®
air dose
°ø±â¼±·®
average dose
Æò±Õ¿ë·®, Æò±Õ¼±·®
biologically effective dose
»ý¹°ÇÐÀûÀ¯È¿¼±·®
booster dose
Ãß°¡Á¢Á¾·®, Ãß°¡¿ë·®
collective effective dose
Áý´ÜÀ¯È¿¼±·®
collective equivalent dose
Áý´Ü´ç·®¼±·®
committed dose equivalent
¿¹Å¹¼±·®ÇØ´ç·®
committed effective dose
¿¹Å¹À¯È¿¼±·®
committed equivalent dose
¿¹Å¹´ç·®¼±·®
cumulative dose
´©Àû·®, ´©Àû¼±·®
curative dose
Ä¡À¯¿ë·®, Ä¡À¯¹æ»ç¼±·®
depth dose curve
½ÉºÎ¼±·®°î¼±
dose-response curve
¿ë·®¹ÝÀÀ°î¼±
percentage depth dose curve
½ÉºÎ¼±·®¹éºÐÀ²°î¼±
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ED 50=ÊÝeffective dose 50%
50% À¯È¿·®.
ED=ÊÝeffective dose
À¯È¿·®.
ID50 (50% infectious dose)
50% °¨¿°·®
LD = lethal dose
Ä¡»ç·®.
LD50 (50% lethal dose)
50% Ä¡»ç·®
LD= lethal dose
Ä¡»ç·®.
MED => minimum effective dose
ÃÖ¼ÒÈ«¹Ý·®
MED=> minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MED=£¾minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MTD=> maximum toderance dose
ÃÖ´ë³»¿ë·®.
MTD=£¾maximum tolerance dose
ÃÖ´ë³»¿ë·®.
MTD=ÊÝmaximum toderance dose
ÃÖ´ë³»¿ë·®.
STD= standard test dose
Ç¥ÁؽÃÇè·®.
absorbed dose
Èí¼ö·®.¹æ»ç¼±Èí¼ö¼±·®(ýåâ¥àÊåÖ).
absorbed dose
Èí¼ö¼±·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
col factor(»ýÈ) cÀÌ ÀÎÀÚ colicin factor
Äݸ®½ÅÀÎÀÚ.
lupus erythematosus factor = LE factor
È«¹Ý¼º ·çǪ½ºÀÎÀÚ(ûõÚèàõ¡ì×í)
adjustable pressure limiting valve
Á¶ÀýÇü ¾Ð·ÂÁ¦ÇÑ ¹ëºê.
anterior limiting membrane
¾Õ°æ°èÆÇ
culture, limiting dilution
ÇѰèÈñ¼®¹è¾ç¹ý, ´ÜÀϼ¼Æ÷¹è¾ç¹ý
external glial limiting membrane
¹Ù±ù¾Æ±³°æ°è¸·
external limiting membrane
¿Ü°æ°è¸·, ¹Ù±ù°æ°èÃþ
gradient limiting reabsorption
³óµµÁõ°¨Á¦ ÇѼº ÀçÈí¼ö.
inner limiting membrane
³»°æ°è¸·.
inner limiting membrane
¼Ó°æ°èÃþ
inner limiting membrane
³»°æ°è¸·, ¼Ó°æ°èÃþ.
internal glial limiting membrane
¼Ó¾Æ±³¼¼Æ÷°æ°è¸·
internal limiting membrane
³»°æ°è¸·.
internal limiting membrane
³»°æ°è¸·, ¼Ó°æ°è¸·.
limiting concentration
ÇѰè³óµµ(¡ÒØöô).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½